Hebei Kexing Pharmaceutical Co., Ltd.

News

Home > News > Warmly congratulating our company on escherichia coli project had passed the approval of agricultural transgenic biology safety (Veterinary drug )

Warmly congratulating our company on escherichia coli project had passed the approval of agricultural transgenic biology safety (Veterinary drug )

2017-03-23


Veterinary drug,industry,In january 2017,the escherichia coli project of hebei kexing pharmaceutical CO. ,LTD had passed the approval of agricultural transgenic biology safety. This project was launched in early 2013,then in turn passed the biological intermediate test, environmental release test and biosafety test within after 4 years.
The escherichia coli project passed the approval meaning the local government expert institutions fully affirmed for our company's research and development capabilities and achievements in recent years.in the future, we will increase our innovation and make the technology center becoming a research platform for new products and new technologies. We will become a platform for attracting and pooling scientific and technological talents, mobilizing and developing its enthusiasm and creativity. To strengthen cooperation in production and research, in accordance with the "Benefit sharing, risk sharing" Principle for development of new products and new technologies, the establishment of research institutes and laboratories, co-training of technical personnel will provide our customers with better service and help.


Send Inquiry

kenneth Yang

Mr. kenneth Yang

Email:

Send Inquiry

Tel:86-311-80677112

Fax:86-311-80677113

Mobile Phone:+8618618225717Contact me with Whatsapp

Email:

Address:NO.114 High And New Technology Industrial Development Zone Luquan, Shijiazhuang, Hebei

Mobile Site

Home

Product

Whatsapp

About Us

Inquiry

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

Send